Vertex Pharmaceuticals | سود قبل از مالیات



Pre Tax Profit تغییر دادن تاریخ
AbbVie USD 4.81B 1.54B 2024-12
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
Agios Pharmaceuticals USD -105399000 1.11B 2024-12
Alnylam Pharmaceuticals USD -193958000 85.3M 2024-12
Amgen USD 3.38B 111M 2024-12
Arrowhead Research USD -175115000 2.32M 2024-12
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 4.26B 226M 2024-12
Gilead Sciences USD 2.96B 112M 2024-12
Incyte USD 406.83M 147.12M 2024-12
Insmed USD -234282000 14.77M 2024-12
Ionis Pharmaceuticals USD -107000000 37M 2024-12
J&J USD 5.42B 1.86B 2024-12
Merck USD 5.22B 114M 2024-12
Moderna USD -1184000000 1.2B 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.66B 269M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
PTC Therapeutics USD -97991000 12.26M 2024-09
Regeneron Pharmaceuticals USD 958.1M 534.9M 2024-12
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.18B 1.33B 2024-12
Sarepta Therapeutics USD 171.74M 137.74M 2024-12
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
United Therapeutics USD 396.5M 7.9M 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



Vertex Pharmaceuticals سود قبل از مالیات - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2025.